(7S,8aR)-Octahydropyrrolo[1,2-a]pyrazin-7-ol oxalate

Catalog No. :
ACMSQV501
CAS No. :
2126143-36-8
Molecular Formula :
C9H16N2O5
Molecular Weight :
232.24

IUPAC Name:(7S,8aR)-octahydropyrrolo[1,2-a]pyrazin-7-ol oxalate

(7S,8aR)-Octahydropyrrolo[1,2-a]pyrazin-7-ol oxalate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$92.00Login to see priceIn stockIn stock
250mg97%$156.00Login to see priceIn stockIn stock
1g97%$412.00Login to see priceIn stockInquiry
5g97%$1998.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(7S,8aR)-Octahydropyrrolo[1,2-a]pyrazin-7-ol oxalate
IUPAC Name(7S,8aR)-octahydropyrrolo[1,2-a]pyrazin-7-ol oxalate
MDL No.MFCD30719371
Molecular FormulaC9H16N2O5
Molecular Weight232.24
SMILESO[C@H](C1)C[C@@]2([H])N1CCNC2.O=C(O)C(O)=O
InChI KeyJVTWONPGZQKRTM-HHQFNNIRSA-N
Synonym2126143-36-8 | (7S,8Ar)-octahydropyrrolo[1,2-a]piperazin-7-ol oxalic acid | (7S,8aR)-Octahydropyrrolo[1,2-a]pyrazin-7-ol oxalate | cis-Octahydropyrrolo[1,2-a]piperazin-7-ol oxalate | (7S,8aR)-octahydropyrrolo[1,2-a]piperazin-7-ol | oxalic acid | cis-octah
CAS No.2126143-36-8
PubChem CID129319832

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACMSQV501 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTUNA967 route compound structure diagram
    ACTUNA9672165392-98-1 In Stock
  2. Then
  3. ACMSQV501 route product structure diagram
    ACMSQV5012126143-36-8 In Stock
Inquiry

2. ACMSQV501 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMSQV501 route product structure diagram
    ACMSQV5012126143-36-8 In Stock
Inquiry

Comments (0)